Skip to main content
Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
115.07
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Arcellx Revenue

In the year 2025, Arcellx had annual revenue of $22.29M, down -79.35%. Arcellx had revenue of $1.65M in the quarter ending December 31, 2025, a decrease of -89.17%.

Revenue (ttm)
$22.29M
Revenue Growth
-79.35%
P/S Ratio
302.95
Revenue / Employee
$106,632
Employees
209
Market Cap
6.75B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202522.29M-85.65M-79.35%
Dec 31, 2024107.94M-2.38M-2.16%
Dec 31, 2023110.32M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Halozyme Therapeutics 1.40B
ImmunityBio 113.29M
Cytokinetics 88.04M
Protagonist Therapeutics 46.02M
Kymera Therapeutics 39.21M
Centessa Pharmaceuticals 15.00M
Revenue Rankings

ACLX News

More News